Menu
Recruiting NCT06831019

The ROAR Study: Reactive Oxygen Species and Reproduction

Observational Ovarian Aging IVF Outcome Oxidative Stress

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Oxidative stress markers.
Who it may be relevant to
Registry conditions: Ovarian Aging, IVF Outcome, Oxidative Stress. Basic parameters: 18 years — 43 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This is a prospective cohort study characterizing follicular fluid and serum levels of oxidative stress in women with various infertility diagnoses undergoing in vitro fertilization, and assessing the relationship of oxidative stress to oocyte competence as determined by embryo development outcomes. Furthermore, we will measure oxidative stress in sperm and correlate the overall oxidative stress within the couple with IVF and pregnancy outcomes of the resultant embryos.

Interventions

  • Diagnostic test Oxidative stress markers
    We will measure markers of oxidative stress in the follicular fluid, semen, and blood and correlate this with IVF and reproductive outcomes

Primary outcome measures

  • Implantation rate [Time frame: From enrollment to transfer of all embryos - can be anywhere from 8 weeks to 1 year (or sometimes longer if pregnancy is achieved)]

Eligibility criteria

Inclusion criteria

  • Female age 18-43 years
  • Subjects planning blastocyst culture for preimplantation genetic screening (PGS) for aneuploidy.
  • Male partners 18 years of age or older.
  • Must be a registered patient at UCSF Center for Reproductive Health
  • Patient and partner must both be physically present on the day of retreival

Exclusion criteria

  • Female partner age 44 or older
  • Planning fresh transfer (hybrid PGS cycle)
  • Cleavage stage biopsy
  • Planning to use frozen sperm

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • University of California, San Francisco — San Francisco

Identifiers

NCT: NCT06831019 · 24-42357

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗